David M. Livingston, M.D.
Affiliations: | Dana-Farber Cancer Institute, Boston, MA, United States |
Area:
Medical Genetics, Hematology, OncologyWebsite:
https://www.dana-farber.org/find-a-doctor/david-m-livingston/Google:
"David M. Livingston"Bio:
http://www.nasonline.org/member-directory/members/1873.html
Mean distance: 21.97 (cluster 51)
Children
Sign in to add traineeJames A. DeCaprio | grad student | Dana-Farber Cancer Institute (Microtree) | |
Sarah James Hill | grad student | 2014 | Harvard |
Maria Guiseppina Baratta | post-doc | Dana-Farber Cancer Institute | |
Sharon Cantor | post-doc | University Of Massachusetts Med Sch Worcester | |
Junjie Chen | post-doc | Dana-Farber Cancer Institute and Harvard Medical School | |
Ronny Drapkin | post-doc | University of Pennsylvania Perelman School of Medicine | |
Marc Ewen | post-doc | Dana-Farber Cancer Institute | |
Jim Figge | post-doc | Dana-Farber Cancer Institute | |
Anthony G. Letai | post-doc | Dana-Farber Cancer Institute (Cell Biology Tree) | |
Ralph Scully | post-doc | Beth Israel Deaconess Medical Center and Harvard Medical School (Cell Biology Tree) | |
William Raj Sellers | post-doc | Dana-Farber Cancer Institute | |
Daniel Silver | post-doc | Thomas Jefferson | |
Brian Wolpin | post-doc | Dana-Farber Cancer Institute | |
Myles Brown | post-doc | 1982-1986 | (Cell Biology Tree) |
William G. Kaelin | post-doc | 1990 | Dana-Farber Cancer Institute (Cell Biology Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Hatchi E, Livingston DM. (2020) Opening a Door to PARP Inhibitor-Induced Lethality in HR-Proficient Human Tumor Cells. Cancer Cell. 37: 139-140 |
Vohhodina J, Toomire KJ, Petit SA, et al. (2020) RAP80 and BRCA1 PARsylation protect chromosome integrity by preventing retention of BRCA1-B/C complexes in DNA repair foci. Proceedings of the National Academy of Sciences of the United States of America |
Wang H, Xiang D, Liu B, et al. (2019) Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer. Cell. 178: 135-151.e19 |
Li AG, Murphy EC, Culhane AC, et al. (2018) BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation. Proceedings of the National Academy of Sciences of the United States of America |
Hill SJ, Mordes DA, Cameron LA, et al. (2016) Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage. Proceedings of the National Academy of Sciences of the United States of America |
Liu JF, Palakurthi S, Zeng Q, et al. (2016) Establishment of patient-derived tumor xenograft models of epithelial ovarian cancer for pre-clinical evaluation of novel therapeutics. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Wang H, Bierie B, Li AG, et al. (2016) BRCA1/FANCD2/BRG1-Driven DNA Repair Stabilizes the Differentiation State of Human Mammary Epithelial Cells. Molecular Cell |
De Nicolo A, Haibe-Kains B, Taşan M, et al. (2016) Analysis of BRCA1-related functional associations in sporadic triple negative breast cancer: A network-based approach. Journal of Clinical Oncology. 34: 1070-1070 |
Brown M, Chinnaiyan A, Farsetti A, et al. (2015) 26th Pezcoller symposium: cancers driven by hormones. Cancer Research. 75: 1177-80 |
Hatchi E, Skourti-Stathaki K, Ventz S, et al. (2015) BRCA1 recruitment to transcriptional pause sites is required for R-loop-driven DNA damage repair. Molecular Cell. 57: 636-47 |